Pricing

Sigilon Therapeutics

2 followers

‌

Sigilon Therapeutics’ mission is to create immune-protected, engineered human cells that restore normal physiology in a wide range of diseases without generating fibrosis or immune rejection, liberating patients from challenges associated with serious chronic diseases.

Industries

Headquarters

Cambridge, United States

Employees

Links

Org chart

Rogerio Vivaldi

President & CEO

Rogerio Vivaldi

Collapse

Chief Technical Operations Officer

Philip Ashton-Rickardt

Chief Scientific Officer

Olivia G. Kelly

VP, Head, Islet Cell Therapy Research

VP & Head, Immune Mediated Diseases

VP, Finance & Controller

VP Of Finance & Controller

Co-founder

Corporate Director

Board & advisors

José Oberholzer

Founder

Founder

Founder

Daniel G. Anderson

Founder & Scientific Advisor

Constance Cepko

Advisor

Advisor

Ulrik B. Nielsen

Advisor

Michael Rosenblatt

Advisor

Teams

Leadership Team

9 members

Administration and Executive Management

11 members

Scientific and Research Team

11 members

Advisors Team

5 members

Finance and Quality Team

4 members

Offices

Similar companies

REVOLUTION Medicines

5 followers

Inari

3 followers

Rigel Pharmaceuticals

3 followers

PureTech Health

3 followers

Arcturus Therapeutics

2 followers

Vividion Therapeutics

1 follower

Keros Therapeutics

1 follower

Relay Therapeutics

1 follower

CHDI Foundation

5 followers

Emerald Cloud Lab

1 follower

Nucleate

3 followers

Explore companies